 |
Cancer Clinical Trials The Newton-Wellesley Hospital Cancer Research Program provides our adult patients and community access to cutting-edge clinical trials. Patients at the Vernon Cancer Center have access to a wide variety of clinical trials including research conducted in collaboration with Massachusetts General Hospital, Brigham and Women’s Hospital and Dana-Farber Partners Cancer Care. Clinical trials advance the understanding of cancer and improve the quality of life for oncology patients. The goals of the research program are to advance knowledge related to cancer prevention, diagnosis, treatment and survival. Newton-Wellesley Hospital has been participating in clinical trials for 21 years. In 2009, the Hospital received approval to become a member of the Cancer and Leukemia Group B (CALGB) which is a national clinical research group sponsored by the National Cancer Institute. In February of 2010, we received approval to become a Clinical Trial Affiliate of Dana-Farber Partners Cancer Care. These approvals allow us to offer patients a greater variety and number of clinical research studies. The Newton-Wellesley Hospital Research Program is accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP) and has maintained this accreditation since July of 2004. This accreditation helps us to ensure that our clinical research program provides the highest quality and protection of the rights and safety of our research participants. Benefits of the Cancer Research Program:
Contact Us
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
